【24h】

Common variants of DNA repair genes and malignant melanoma.

机译:DNA修复基因和恶性黑色素瘤的常见变异。

获取原文
获取原文并翻译 | 示例
       

摘要

In the current study, we evaluated the possible associations of seven common variants of the DNA repair and cell cycle control genes BRCA2 and CHEK2 with malignant melanoma (MM). We genotyped 630 unselected MM patients and over 3700 controls (newborns, age- and sex-matched healthy adults with negative cancer family histories, and the adults selected at random by family doctors) for the prevalence of three common variants of the BRCA2 (T1915M, N991D and N372H) and four common variants of the CHEK2 (1100delC, VS2+1G-->A, I157T and del5395). Our study strongly suggests that the common variant of the BRCA2 gene - the N991D variant is associated with malignant melanoma risk (OR=1.8, p=0.002 after Bonferroni correction). Patients homozygote for the N991D variant were present in 0.32% of cases and only 0.13% of controls. The other variants studied were not over-represented among MM patients when compared to the general population. In conclusion, we report an increased melanoma risk among carriers of the N991D change of the BRCA2 and no association of the CHEK2 changes with malignant melanoma.
机译:在当前的研究中,我们评估了DNA修复和细胞周期控制基因BRCA2和CHEK2的七个常见变异与恶性黑色素瘤(MM)的可能联系。我们对630例未选择的MM患者和3700例对照(新生儿,年龄和性别匹配且癌症家族史为阴性的健康成年人,以及由家庭医生随机选择的成年人)进行了基因分型,以了解BRCA2的三种常见变体(T1915M, N991D和N372H)以及CHEK2的四个常见变体(1100delC,VS2 + 1G-> A,I157T和del5395)。我们的研究强烈表明,BRCA2基因的常见变体-N991D变体与恶性黑色素瘤风险相关(OR = 1.8,Bonferroni矫正后p = 0.002)。 N991D变体的纯合子患者占0.32%,对照组仅为0.13%。与普通人群相比,研究的其他变体在MM患者中并未过多代表。总之,我们报道了携带BRCA2的N991D改变的携带者中黑色素瘤的风险增加,而CHEK2改变与恶性黑色素瘤之间没有关联。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号